Kartenos vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 97,963 | 114,732 | 135,259 | 134,783 | 152,272 | 185,156 | 200,371 | 222,273 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -1,426 | 3,008 | 2,004 | -1,838 | -94 | 17,630 | -5,570 | 7,342 |
| Equity | 17,158 | 20,165 | 22,170 | 20,224 | 20,130 | 37,759 | 25,189 | 24,530 |
| Liabilities | 12,573 | 14,416 | 17,384 | 18,032 | 20,919 | 21,863 | 24,684 | 0 |
| Non-current assets | 6,394 | 6,080 | 6,807 | 6,335 | 5,921 | 5,506 | 5,494 | 5,073 |
| Current assets | 23,337 | 28,501 | 32,747 | 31,921 | 35,128 | 54,116 | 44,379 | 43,280 |
| Total assets | 29,731 | 34,581 | 39,554 | 38,256 | 41,049 | 59,622 | 49,873 | 48,353 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 3,624 | 4,530 | 5,213 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +3.7% | +17.1% | +17.9% | -0.4% | +13.0% | +21.6% | +8.2% | +10.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -4.8% | 8.7% | 5.1% | -4.8% | -0.2% | 29.6% | -11.2% | 15.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -8.3% | 14.9% | 9.0% | -9.1% | -0.5% | 46.7% | -22.1% | 29.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.5% | 2.6% | 1.5% | -1.4% | -0.1% | 9.5% | -2.8% | 3.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 0.7 | 0.8 | 0.9 | 1.0 | 0.6 | 1.0 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 48,982 | 57,366 | 67,630 | 67,392 | 76,136 | 92,578 | 100,186 | 111,137 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Kartenos vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-01-17 | 2023-01-19 | 0.01 |
Kartenos vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-04 | 2025-04-04 | 341.48 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Kartenos vaistine, UAB (code 164146410) is a Private Limited Liability Company operating in retail sale of pharmaceutical products. In 2025, the company generated revenue of €222.3K and net profit of €7.3K, corresponding to a profit margin of 3.3%. Revenue increased by 10.9% year on year and by 20.1% over the two-year period from 2023 to 2025, showing steady top-line growth. Profitability was more volatile: net profit was €17.6K in 2023, turned into a €5.6K loss in 2024, and recovered to a positive result in 2025. At year-end 2025, total assets stood at €48.4K, with equity of €24.5K and liabilities not stated for that year. The equity ratio was 50.7%, asset turnover was 4.60x, ROE was 29.9%, and ROA was 15.2%. The business also showed solid productivity, with revenue per employee of €111.1K and profit per employee of €3.7K.